- Quince Therapeutics (NASDAQ:QNCX) has registered up to 17.34M shares of common stock for resale by selling stockholders.
- The registration includes 6.67M existing shares and up to 10.67M shares issuable upon exercise of warrants.
- Of the warrants, 2M are pre-funded and 8.67M are
Quince Therapeutics registers up to 17.3M shares for resale by investors

Related
Is a ‘pretty good’ Alexa+ good enough to pull off a comeback...
14 minutes ago
0
‘Feels bad and dangerous’: OpenAI CEO Sam Altman uneasy over...
16 minutes ago
0
Sarepta denies Elevidys is linked to latest patient death in...
27 minutes ago
0
LANDBANK powers cashless fare payments in MRT-3
4 hours ago
0
Trending
Popular
شکست سنگین ذوبآهن در اردوی ترکیه
5 days ago
3
© FBT Company 2025. All rights are reserved